🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 11 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/05/2018 93,59 93,95 90,34 91,85 -2,24% 3,86% 1.354.700
16/05/2018 92,49 95,67 91,95 93,95 +1,38% 4,02% 1.046.200
15/05/2018 92,70 94,55 91,44 92,67 -0,46% 3,35% 919.100
14/05/2018 93,04 95,50 91,23 93,10 +0,23% 4,59% 1.136.200
11/05/2018 91,50 93,92 90,10 92,89 +2,85% 4,17% 1.829.200
10/05/2018 90,50 92,79 88,57 90,32 -0,17% 4,66% 1.125.800
09/05/2018 85,96 90,81 84,09 90,47 +5,62% 7,82% 1.409.500
08/05/2018 90,08 90,08 84,16 85,66 -5,03% 6,57% 2.226.000
07/05/2018 90,00 92,98 88,78 90,20 +0,50% 4,67% 2.219.000
04/05/2018 76,29 90,99 76,20 89,75 +14,81% 19,39% 5.688.000
03/05/2018 78,11 79,61 77,19 78,17 -0,31% 3,10% 1.217.200
02/05/2018 77,57 79,57 77,18 78,41 +0,72% 3,08% 732.500
01/05/2018 76,22 78,17 75,83 77,85 +1,95% 3,07% 847.500
30/04/2018 78,65 79,24 76,34 76,36 -2,76% 3,69% 761.000
27/04/2018 79,62 79,80 77,72 78,53 -0,53% 2,61% 672.500
26/04/2018 78,19 79,90 77,65 78,95 +1,48% 2,88% 635.800
25/04/2018 76,59 78,17 74,51 77,80 +1,83% 4,78% 1.068.900
24/04/2018 78,49 79,17 75,26 76,40 -2,44% 4,98% 1.033.200
23/04/2018 80,61 80,68 76,54 78,31 -2,10% 5,14% 1.348.200
20/04/2018 78,21 80,87 77,67 79,99 +1,83% 4,09% 1.297.300
19/04/2018 80,39 81,56 77,46 78,55 -2,98% 5,10% 1.087.100
18/04/2018 80,32 81,54 79,83 80,96 +1,36% 2,13% 660.500
17/04/2018 79,17 80,72 77,74 79,87 +1,80% 3,76% 764.000
16/04/2018 81,36 81,99 78,04 78,46 -2,90% 4,85% 862.700
13/04/2018 83,30 83,30 80,01 80,80 -2,43% 3,95% 976.500
12/04/2018 80,96 83,88 80,42 82,81 +3,01% 4,27% 1.336.500
11/04/2018 78,36 80,99 77,90 80,39 +1,88% 3,94% 1.347.400
10/04/2018 76,72 79,36 76,06 78,91 +4,59% 4,30% 1.567.200
09/04/2018 72,92 78,36 72,87 75,45 +5,17% 7,53% 1.940.300
06/04/2018 71,82 73,31 71,01 71,74 -1,54% 3,20% 759.500